Page last updated: 2024-10-22

alendronate and Synovitis

alendronate has been researched along with Synovitis in 4 studies

alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.

Synovitis: Inflammation of the SYNOVIAL MEMBRANE.

Research Excerpts

ExcerptRelevanceReference
"We describe 7 cases of synovitis or arthritis occurring after commencement of alendronate for treatment of osteoporosis."7.74Alendronate-induced synovitis. ( Gwynne Jones, DP; Highton, J; Savage, RL, 2008)
"We describe 7 cases of synovitis or arthritis occurring after commencement of alendronate for treatment of osteoporosis."3.74Alendronate-induced synovitis. ( Gwynne Jones, DP; Highton, J; Savage, RL, 2008)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jones, DG1
Savage, R1
Highton, J2
Frederiksen, L1
Junker, P1
Brixen, KT1
Gwynne Jones, DP1
Savage, RL1

Other Studies

4 other studies available for alendronate and Synovitis

ArticleYear
Synovitis induced by alendronic acid can present as acute carpal tunnel syndrome.
    BMJ (Clinical research ed.), 2005, Jan-08, Volume: 330, Issue:7482

    Topics: Aged; Alendronate; Carpal Tunnel Syndrome; Female; Humans; Osteoporosis, Postmenopausal; Synovitis;

2005
Alendronic acid: synovitis, myalgia and arthralgia.
    Prescrire international, 2007, Volume: 16, Issue:88

    Topics: Alendronate; Arthralgia; Diphosphonates; Female; Humans; Musculoskeletal Diseases; New Zealand; Syno

2007
[Persistent polyarticular synovitis after treatment with alendronate].
    Ugeskrift for laeger, 2007, Apr-23, Volume: 169, Issue:17

    Topics: Alendronate; Arthritis; Bone Density Conservation Agents; Female; Humans; Middle Aged; Osteoporosis,

2007
Alendronate-induced synovitis.
    The Journal of rheumatology, 2008, Volume: 35, Issue:3

    Topics: Aged; Alendronate; Arthritis; Bone Density Conservation Agents; Female; Humans; Middle Aged; Osteopo

2008